A Study to Determine
the Safety And Efficacy Of an Ultrasound Device in the
Management of Acne Vulgaris
Description –
The purpose of this study is to determine the safety and
effectiveness of an investigational device for acne. The
study may last up to 4 weeks and subjects will receive $630
for completing the study visits. Nine study visits are
required. To participate in this research study, the subject
will have to stop all other treatments for acne except
emollients approved by the study doctor. Please feel free to
call our office at (617) 726-5066 Monday through Friday
between 9:00 am and 5:00pm for more information.
Eligibility Criteria – Subjects 18 years of age
and older with acne. If you are female, you cannot be
pregnant or breast-feeding. Other restrictions will be
explained at the screening visit.
Institution - Massachusetts General Hospital
Principal Investigator -
Alexandra B. Kimball MD, MPH
Enrollment Information -
For further information about enrolling as a subject in this
trial please email us at:
harvardskinstudies@partners.org or call
Lynne Hermosilla
at (617) 726-5066.
|
